FDA granted Orphan Drug designation to rhenium obisbemeda (186Re) for the treatment of leptomeningeal metastases in patients with lung cancer.
Amid the flood zone of today’s Washington, the confirmation hearing for Jayanta (Jay) Bhattacharya’s nomination as director of NIH was remarkably calm.
In a speech before a joint session of Congress, President Trump briefly addressed pediatric cancer, pointing to a 13-year old brain tumor survivor, Devarjaye “DJ” Daniel, who was watching from the gallery, making his dream come true by naming him a Secret Service agent.
Each year, nearly 14 million people in the U.S. contract human papillomavirus, a common, sexually-transmitted virus that can cause several cancers.
As cancer specialists, we have to constantly be on the lookout, alert for trends as they emerge—because they might impact the way we best deliver advice or care, or because trends may inform us about specific influences that drive cancers.
Emma Lee Wen knows exactly what science can accomplish.
Jeffrey C. Rathmell, an immune and cancer cell metabolism researcher, was named chair of the Ben May Department for Cancer Research and director of the Ludwig Center for Metastasis Research at the University of Chicago, effective July 1.
Monica Bertagnolli, former director of NIH and NCI, joined the Friends of Cancer Research as board of directors.
Megan Melody joined the Tampa General Hospital Cancer Institute Cellular Therapy team. She was formerly at the McGaw Medical Center of Northwestern University.
The University of Texas MD Anderson Cancer Center and Texas Children’s Hospital have announced a collaboration focused on pediatric cancer care.
